Nonmedication smoking reduction program for inpatients with chronic schizophrenia: A randomized control design study

Marc Gelkopf, Sigalit Noam, Dimitri Rudinski, Arturo Lerner, Pnina Behrbalk, Avi Bleich, Yuval Melamed

Research output: Contribution to journalArticlepeer-review


People with schizophrenia are more likely to smoke, and to smoke more frequently, than those without schizophrenia. Furthermore, inpatients smoke even more frequently compared with those living in the community. In light of this, we implemented and assessed a smoking reduction intervention using a wide array of behavioral group techniques and methods in chronic hospitalized schizophrenic clients. Using a controlled design, we randomly assigned chronic schizophrenic clients to either a five-session smoking reduction intervention (n = 35) or a waiting list (WL; n = 18). We assessed self-reported smoking behavior, clinical status (Positive and Negative Syndrome Scale, Hamilton Rating Scale for Depression; Clinical Global Impression Scale for Psychosis), subjective quality of life (Quality of Life Enjoyment and Satisfaction Questionnaire-abbreviated version), and weight before and 3 months after the intervention. The intervention successfully reduced the number of cigarettes smoked compared with nonintervention. No clinical worsening or weight gain was observed. Behavioral group-oriented smoking reduction interventions can significantly reduce smoking behavior in hospitalized chronic clients with schizophrenia.

Original languageEnglish
Pages (from-to)142-146
Number of pages5
JournalJournal of Nervous and Mental Disease
Issue number2
StatePublished - Feb 2012


  • Psychiatric inpatient
  • Psychiatric institution
  • Schizophrenia
  • Smoking reduction

ASJC Scopus subject areas

  • Psychiatry and Mental health


Dive into the research topics of 'Nonmedication smoking reduction program for inpatients with chronic schizophrenia: A randomized control design study'. Together they form a unique fingerprint.

Cite this